Last reviewed · How we verify
Antimicrobials
The antimicrobial drug developed by Endeavor Health has been discontinued and its intended indication is not specified. As a result, its potential significance in treating infections is unclear. The discontinuation of this drug may have been due to various reasons such as lack of efficacy or safety concerns.
At a glance
| Generic name | Antimicrobials |
|---|---|
| Sponsor | Endeavor Health |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital (N/A)
- Are Long Term Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)? (Phase 1)
- A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 (Phase 1)
- Aggressive Versus Restrictive Initiation of Antimicrobial Treatment in Critically Ill Patients With Suspected Ventilator Acquired Pneumonia Without Severity : a Before and After Observational Study (N/A)
- Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux. A Randomised Prospective Study of Continuous Low Dose of Trimethoprim-Sulfamethoxazole Versus Surveillance. (NA)
- Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in Idiopathic Pulmonary Fibrosis (Phase 3)
- A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemoth (Phase 2)
- The Evaluation of the Curative Effect of Electrophysiological Rehabilitation Services on Endometrial Repair After Induced Abortion (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antimicrobials CI brief — competitive landscape report
- Antimicrobials updates RSS · CI watch RSS
- Endeavor Health portfolio CI